%0 Journal Article
%T Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
%A Chih-Jen Yang
%A Inn-Wen Chong
%A Jen-Yu Hung
%A Jui-Ying Lee
%A Mei-Chiou Shen
%A Ming-Ju Tsai
%A Ming-Shyan Huang
%A Shah-Hwa Chou
%A Ta-Chih Liu
%A Ying-Ming Tsai
%J Archive of "OncoTargets and therapy".
%D 2016
%R 10.2147/OTT.S100169
%X Readministering a second epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in patients with lung adenocarcinoma with acquired resistance to an initial EGFR TKI is a common treatment strategy. However, the prognostic factors for the second EGFR TKI are still uncertain
%K lung cancer
%K adenocarcinoma
%K epidermal growth factor receptor tyrosine kinase inhibitor
%K gefitinib
%K erlotinib
%K smoker
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801161/